*Cayuse 424* Downtime Saturday 9/12 – 9AM-9PM
Dear Colleagues, Cayuse will have its monthly maintenance window on Saturday, 9/12/20, from 9am-9pm Pacific. During this time, Cayuse 424 will be temporarily unavailable. Please save your work and exit out of the system before the downtime. Please let the ERA Team know if you have any questions. Thanks! The ERA Team
Read MoreKR Downtime tonight (9/9) from 8-9pm
Dear Kuali Research (KR) Users, KR will be unavailable tonight, 9/9, from 8-9PM for our regular monthly deployment. If you have any questions regarding tonight’s deployment, please contact us at era@research.uci.edu. Thank you, The ERA Team
Read MoreeRA Enhancement: Ability to Select Awarded Components on RPPR Screen, Instead of Manually Adding for Multi-Project Awards
Dear Colleagues: Please see an important message below regarding enhancements made to the RPPR functionality for Multi-Project awards in NIH’s ERA Commons. Nancy Nancy LewisExecutive Director, Sponsored Projects AdministrationOffice of ResearchUniversity of California, Irvine COVID-19: In response to the SARS-CoV-2/COVID-19 (Coronavirus ) pandemic, the Office of Research will be telecommuting. During this time, email is the…
Read MoreTranslated HIPAA Research Forms
Institutional Review Board Human Research Protections (HRP) Translated HIPAA Research Forms Version August 31, 2020 Foreign language translatedHIPAA Research Authorization Forms are posted on the Applications and Forms webpage under the subsection, ‘Human Research Protections’ and then, ‘Foreign Language Translations.’ Reminder: Since early 2020, one form now covers UCI providers and non-UCI…
Read MoreTranslated HIPAA Research Forms
Institutional Review Board Human Research Protections (HRP) Translated HIPAA Research Forms Version August 31, 2020 Foreign language translatedHIPAA Research Authorization Forms are posted on the Applications and Forms webpage under the subsection, ‘Human Research Protections’ and then, ‘Foreign Language Translations.’ Reminder: Since early 2020, one form now covers UCI providers and non-UCI…
Read MoreProgram Update: Removal of Exempt 4iii
Institutional Review Board Human Research Protections (HRP) Program Update: Removal of Exempt 4iii Version August 28, 2020 The 2018 Common Rule went into effect on January 21, 2019, specifying revised exempt research categories under 45 CFR 46. 104. One of the revised categories, Exempt 4iii allows for the secondary use of existing…
Read MoreProgram Update: Removal of Exempt 4iii
Institutional Review Board Human Research Protections (HRP) Program Update: Removal of Exempt 4iii Version August 28, 2020 The 2018 Common Rule went into effect on January 21, 2019, specifying revised exempt research categories under 45 CFR 46. 104. One of the revised categories, Exempt 4iii allows for the secondary use of existing…
Read MoreUC Irvine Response to Research Data Ransomware Threat
UC Irvine Response to Research Data Ransomware Threat August 25, 2020 Dear Colleagues: We are writing to you today so that you are aware of a recent ransomware attack targeting UCSF researchers and their data. In this case, UCSF paid a significant sum of money (in bitcoin) to decrypt the ransomed data. UCSF made this…
Read MorePolicy Update – Results Information Reporting for Applicable Clinical Trials (ACTs)
Institutional Review Board Human Research Protections (HRP) Policy Update – Results Information Reporting for Applicable Clinical Trials (ACTs) (NOT-OD-20-147) Version August 18, 2020 Update: A Federal court has held that Section 801 of the Food and Drug Administration Amendments Act of 2007 (“FDAAA”) requires submission of results information for any “applicable clinical…
Read MorePolicy Update – Results Information Reporting for Applicable Clinical Trials (ACTs)
Institutional Review Board Human Research Protections (HRP) Policy Update – Results Information Reporting for Applicable Clinical Trials (ACTs) (NOT-OD-20-147) Version August 18, 2020 Update: A Federal court has held that Section 801 of the Food and Drug Administration Amendments Act of 2007 (“FDAAA”) requires submission of results information for any “applicable clinical…
Read More